University of Edinburgh
Decoding functional consequences of TP53 mutations through single-cell RNA sequencing
Abstract
dc:description.abstractThe TP53 gene encodes the tumour suppressor protein p53, which is the most frequently mutated gene across human cancers. Mutants in TP53 result in loss-of-function, dominant-negative effects, or gain-of-function phenotypes that promote tumourigenesis. Understanding how specific TP53 mutants alter gene expression and cellular pathways remains a challenge due to the diversity of mutations and their context-dependent effects across cell types and signalling networks. To systematically measure the functional consequences of TP53 mutations, I developed a high-throughput platform combining saturation mutagenesis, barcoded genome integration, and single-cell RNA sequencing (scRNA-seq). A saturation mutagenesis library of TP53 was linked to unique DNA barcodes, enabling precise identification of each variant. Using the HEK293 Flp-In T-REx system and MaxCyte electroporation, I achieved single-copy, inducible integration of individual TP53 variants, ensuring consistent genomic context and expression control. Following induction of TP53 variant expression, pooled mutant libraries were either exposed or unexposed to X-ray irradiation. Single-cell transcriptomes were generated using Split-Pool Ligation-based Transcriptome sequencing (SPLiT-seq). Pathway-level analyses comparing wild-type and mutant domains were performed, and missing variant-level measurements were inferred using predictive modelling approaches. I obtained transcriptome profiles for 3107 p53 variants across 37183 cells, representing approximately 40% of all possible single amino acid substitutions across the p53 protein sequence. Differential expression analysis revealed distinctions between wild-type and mutant groups. X-ray exposure induced marked transcriptional shifts, while mutations in the DNA-binding domain predominantly exhibited loss-of-function characteristics. In contrast, variants within the C-terminal regulatory domain retained or showed increased pathway activity relative to wild-type. Gene set enrichment and hallmark analyses identified further mutation-specific pathway differences. In addition to the TP53 work, I performed a pilot scRNA-seq experiment using 26 transcription factor (TF) sequences. This identified TF-specific differential gene expression, and preliminary Gene Ontology analysis linked the top genes to relevant biological processes. This approach provides a scalable, quantitative framework to functionally annotate TP53 mutations in an isogenic background. It demonstrates the feasibility of coupling saturation mutagenesis with scRNA-seq to uncover mutation-specific phenotypes and pathway alterations. Future work will expand this platform to explore additional transcription factors and assess responses to stress and drug treatments.
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Bhuiyan, Nabid
- Advisors dc:contributor.advisor
-
- Kudla, Grzegorz
- Hupp, Ted
Subjects
dc:subject × 5Rights
- Language dc:language.iso
- en
Identifiers
dc:identifier.*- Identifier URI
- https://doi.org/10.7488/era/7817